Immunological effects and safe administration of alemtuzumab (MabCampath) in advanced B-cLL. (Q34785892)
scientific article
Language:
(P31) (Q13442814)
(P50) (Q48086375)
(P304) S49-55
(P478) 19 Suppl
(P577) Tuesday, January 1, 2002
(P921) (Q101929)
(P1433) (Q2152666)
(P1476) "Immunological effects and safe administration of alemtuzumab (MabCampath) in advanced B-cLL" (language: en)
(P2093) Ben Kennedy
Peter Hillmen
(P2860) (Q34065579)
(Q72088966)
(Q58041667)
(Q33915548)
(Q70802907)
(Q64958084)
(Q41493789)
(Q33342242)
(Q71257873)
(Q77368695)
(Q33874321)
(Q40682805)
(Q41705074)
(Q33763834)
(Q34065189)
(Q40896069)
(Q40607860)
(Q41304856)
(Q40632321)
(Q40539671)
(Q40678725)
(Q70859020)
(Q34086162)
(Q39528965)
(Q40477416)
(Q77364130)
(Q49151897)
(Q39893662)
(Q33337233)
(Q77435839)
(Q41712582)
(Q73442099)
(Q33330593)
(Q36379517)
(Q39620728)
(Q40949199)
(Q41706204)
(Q28144207)
(Q33944186)
(Q33499555)
(Q73984185)
(P13046) (Q7318358)
other details
description scientific article

External Links